Literature DB >> 12242039

Expression of chromogranin A and somatostatin receptors in pancreatic AR42J cells.

Eva Hofsli1, Liv Thommesen, Kristin Nørsett, Sture Falkmer, Unni Syversen, Arne Sandvik, Astrid Laegreid.   

Abstract

The exocrine pancreatic cell line AR42J is also known to display some neuroendocrine (NE) features. We have extended this fact by showing that AR42J cells express mRNA of chromogranin A (CgA), display immunoreactivity (IR) to CgA, and secrete its cleavage product pancreastatin. A sparse occurrence of typical NE secretion granules, together with only a faint IR to conventional NE markers, indicates that the NE cells are of a poorly differentiated type. CgA promoter reporter plasmid experiments showed that gastrin, epidermal growth factor, and phorbol 12-myristate 13-acetate, induce upregulation of CgA after 24 h. By RT-PCR, it was found that AR42J expresses all of the five subtypes of the somatostatin (SST) receptor (SSTR) family, except SSTR4. The existence of functional SSTRs was confirmed by showing that the SST analog octreotide could inhibit gastrin-induced proliferation. Thus, the AR42J cell line may function as a valuable experimental model to study the regulation of CgA and SSTRs in poorly differentiated NE tumor cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242039     DOI: 10.1016/s0303-7207(02)00131-4

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  10 in total

Review 1.  Genes involved in neuroendocrine tumor biology.

Authors:  Eva Hofsli
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

2.  Preparation and biological evaluation of 64Cu-CB-TE2A-sst2-ANT, a somatostatin antagonist for PET imaging of somatostatin receptor-positive tumors.

Authors:  Thaddeus J Wadas; Martin Eiblmaier; Alexander Zheleznyak; Christopher D Sherman; Riccardo Ferdani; Kexian Liang; Samuel Achilefu; Carolyn J Anderson
Journal:  J Nucl Med       Date:  2008-10-16       Impact factor: 10.057

3.  Myosin Vc is a molecular motor that functions in secretory granule trafficking.

Authors:  Damon T Jacobs; Roberto Weigert; Kyle D Grode; Julie G Donaldson; Richard E Cheney
Journal:  Mol Biol Cell       Date:  2009-09-09       Impact factor: 4.138

4.  The duration of gastrin treatment affects global gene expression and molecular responses involved in ER stress and anti-apoptosis.

Authors:  Linn-Karina M Selvik; Christina S Fjeldbo; Arnar Flatberg; Tonje S Steigedal; Kristine Misund; Endre Anderssen; Berit Doseth; Mette Langaas; Sushil Tripathi; Vidar Beisvag; Astrid Lægreid; Liv Thommesen; Torunn Bruland
Journal:  BMC Genomics       Date:  2013-06-28       Impact factor: 3.969

5.  Combination of terbium-161 with somatostatin receptor antagonists-a potential paradigm shift for the treatment of neuroendocrine neoplasms.

Authors:  Francesca Borgna; Stephanie Haller; Josep M Monné Rodriguez; Mihaela Ginj; Pascal V Grundler; Jan Rijn Zeevaart; Ulli Köster; Roger Schibli; Nicholas P van der Meulen; Cristina Müller
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-08       Impact factor: 9.236

6.  Identification of novel growth factor-responsive genes in neuroendocrine gastrointestinal tumour cells.

Authors:  E Hofsli; L Thommesen; F Yadetie; M Langaas; W Kusnierczyk; U Falkmer; A K Sandvik; A Laegreid
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

Review 7.  The Search for an Alternative to [68Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of 18F-labeled Somatostatin Analog Development.

Authors:  Christopher M Waldmann; Andreea D Stuparu; R Michael van Dam; Roger Slavik
Journal:  Theranostics       Date:  2019-02-14       Impact factor: 11.556

8.  Simultaneous Visualization of 161Tb- and 177Lu-Labeled Somatostatin Analogues Using Dual-Isotope SPECT Imaging.

Authors:  Francesca Borgna; Patrick Barritt; Pascal V Grundler; Zeynep Talip; Susan Cohrs; Jan Rijn Zeevaart; Ulli Köster; Roger Schibli; Nicholas P van der Meulen; Cristina Müller
Journal:  Pharmaceutics       Date:  2021-04-12       Impact factor: 6.321

9.  Radiopharmaceutical Formulation and Preclinical Testing of 68Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial.

Authors:  Anton A Hörmann; Maximilian Klingler; Christine Rangger; Christian Mair; Clemens Decristoforo; Christian Uprimny; Irene J Virgolini; Elisabeth von Guggenberg
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-16

10.  Gastrin-induced proliferation involves MEK partner 1 (MP1).

Authors:  Tonje S Steigedal; Wenche S Prestvik; Linn-Karina M Selvik; Christina S Fjeldbo; Torunn Bruland; Astrid Lægreid; Liv Thommesen
Journal:  In Vitro Cell Dev Biol Anim       Date:  2013-02-14       Impact factor: 2.416

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.